GSK

OTC: GLAXF · Real-Time Price · USD
19.25
0.15 (0.79%)
At close: Aug 14, 2025, 12:18 PM
19.25
0.03%
After-hours: Aug 13, 2025, 08:00 PM EDT

GSK Cash Flow Statement

Financials in GBP. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
3.98B 3.51B 2.79B 2.63B 4.1B 4.67B 5.26B 6.54B 5.78B 4.38B 4.92B 4.23B 4.82B 6B 5.1B 5B 5.07B 5.97B
Depreciation & Amortization
3.35B 2.83B 2.55B 3.32B 2.94B 2.76B 2.85B 1.53B 1.9B 2.08B 2.15B 2.8B 2.83B 2.87B 2.52B 2.96B 2.62B 791M
Stock-Based Compensation
n/a n/a n/a 307M 307M 307M 307M n/a n/a n/a n/a 343M 343M 343M 343M 393M 393M 393M
Other Working Capital
1.2B 1.91B 2.09B 1.28B 2.19B 516M 283M -1.73B -2.37B 101M 767M 1.86B 2.38B 2.03B 824M -255M -977M 479M
Other Non-Cash Items
-805M -135M 1.28B 6.47B 4.53B 4.64B 2.51B -853M -733M -1.66B 65M -85M -64M 5M -1.09B -714M -1.03B -661M
Deferred Income Tax
n/a n/a n/a -865M -865M -865M -865M n/a n/a n/a n/a -1B -1B -1B -1B n/a n/a n/a
Change in Working Capital
1.2B 1.59B 2.06B 118M 1.02B -327M -856M -1.73B -2.37B 101M 270M 2.32B 2.92B 1.29B 1.42B 784M -316M 1.71B
Operating Cash Flow
7.72B 6.51B 6.3B 6.95B 7B 7.43B 6.54B 5.48B 4.59B 4.91B 7.4B 9.27B 10.51B 10.16B 7.95B 8.04B 6.34B 7.81B
Capital Expenditures
-3.06B -2.87B -2.98B -2.63B -2.29B -2.38B -2.34B -2.31B -2.29B -2.19B -2.26B -2.14B -2.94B -3.18B -2.93B -3.14B -2.51B -2.25B
Cash Acquisitions
-975M -972M -867M -773M -829M -1.34B -669M -673M -3.59B -3.12B -3.14B -3.16B -210M 200M 185M 217M 309M 2.67B
Purchase of Investments
n/a -32M -50M -81M -114M -85M -123M -92M -122M -133M -122M -138M -99M -105M -42M -41M -206M -368M
Sales Maturities Of Investments
n/a 1.24B 2.32B 3.34B 3.41B 2.97B 1.91B 882M 924M 126M 115M 122M 32M 435M 497M 625M 864M 3.29B
Other Investing Acitivies
-1.33B -1B -867M 368M 817M 137M 331M -521M -1.24B -589M -3.73B -3.51B -3.7B -3.95B -712M -151M -81M -4.37B
Investing Cash Flow
-3.62B -2.26B -1.32B 6M 246M -1.45B -1.66B -2.4B -6.01B -5.59B -8.77B -8.59B -5.68B -5.32B -1.78B -1.47B -845M 2.17B
Debt Repayment
740M 1.07B -1.17B -4.18B -4.68B -3.1B -2.37B -6M -113M -3.96B -4.62B -5.63B -4.71B -2.24B -2B -1.09B -3.7B -3.9B
Common Stock Repurchased
-808M -247M n/a n/a n/a n/a -2M -2M -2M 2M -3M -3M -3M -7M n/a n/a n/a n/a
Dividend Paid
-2.49B -2.49B -2.44B -2.4B -2.35B -2.26B -2.25B -2.33B -2.47B -3.07B -3.47B -3.76B -4.01B -4B -4B -3.99B -3.99B -3.98B
Other Financial Acitivies
-1.05B -1.16B -1.06B -846M -916M -973M -1.03B -1.06B -384M -454M 8.89B 8.76B 8.02B 7.99B -1.61B -1.92B -2.21B -2.6B
Financial Cash Flow
-3.6B -2.54B -4.38B -6.85B -7.37B -6.03B -5.36B -3.39B -2.95B -7.47B 823M -613M -681M 1.76B -7.59B -6.99B -9.87B -10.46B
Net Cash Flow
445M 1.54B 550M -66M -233M -88M -646M -332M -4.39B -8.03B -392M 160M 4.23B 6.62B -1.44B -462M -4.48B -594M
Free Cash Flow
4.67B 3.64B 3.32B 4.32B 4.72B 5.05B 4.2B 3.17B 2.29B 2.73B 5.14B 7.13B 7.56B 6.99B 5.02B 4.9B 3.83B 5.56B